痛風治療薬の世界市場2016-2020...市場調査レポートについてご紹介

【英文タイトル】Global Gout Therapeutics Market 2016-2020

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Gout: Disease overview

PART 06: Pipeline portfolio

PART 07: Market landscape
• Market overview
• Five forces analysis

PART 08: Key buying criteria

PART 09: Market segmentation by drug class
• NSAIDs
• Corticosteroids
• Colchicine
• Urate-lowering agents

PART 10: Market segmentation by type of disease

PART 11: Geographical segmentation
• Gout therapeutics market in Americas
• Gout therapeutics market in EMEA
• Gout therapeutics market in APAC
• Market overview

PART 12: Market drivers
• Introduction of novel urate-lowering agents
• Technological advancements in medical imaging
• Popularity of off-label and OTC drugs

PART 13: Impact of drivers

PART 14: Market challenges
• Low physician and patient awareness
• Heavy dependency on generic drugs
• Use of CAM for treatment of gout

PART 15: Impact of drivers and challenges

PART 16: Market trends
• Focus on regenerative medicines
• High growth potential of biologics
• Preference for combination therapies

PART 17: Vendor landscape
• Competitive scenario
• Other prominent vendors

PART 18: Key vendor analysis
• AstraZeneca
• Horizon Pharma
• Takeda Pharmaceuticals

PART 19: Appendix
• List of abbreviations

PART 20: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Global gout therapeutics market overview
Exhibit 03: Stages of gout
Exhibit 04: Mechanism of gout
Exhibit 05: Gout: overview
Exhibit 06: Treatment algorithm for gout
Exhibit 07: Pipeline analysis of major companies for global gout therapeutics market
Exhibit 08: Share of pipeline molecules in global gout therapeutics market
Exhibit 09: Few pipeline candidates under development in global gout therapeutics market:
Exhibit 10: Market snapshot: Global gout therapeutics market
Exhibit 11: Global statistics for gout in 2015
Exhibit 12: Correlation between serum uric acid concentration and cigarette smoking status
Exhibit 13: Factors influencing the global gout therapeutics market 2015
Exhibit 14: Global gout therapeutics market snapshot: Developed and emerging markets 2015
Exhibit 15: Global gout therapeutics market 2015-2020 ($ billions)
Exhibit 16: Opportunities in gout arthritis industry today
Exhibit 17: Impact of drivers and challenges of global gout therapeutics market
Exhibit 18: Five forces analysis
Exhibit 19: Key buying criteria for gout therapeutics market
Exhibit 20: Key buying criteria for global gout therapeutics market 2015
Exhibit 21: Impact of key customer segments on global gout therapeutics market 2015
Exhibit 22: Market segmentation by drug class: Global gout therapeutics market
Exhibit 23: Common NSAIDs used for treatment of gout
Exhibit 24: Market segmentation by drug class: Present and future scenarios
Exhibit 25: Global gout therapeutics market: Segmentation by type 2015-2020
Exhibit 26: Global gout therapeutics market segmentation: Growth cycle analysis
Exhibit 27: Snapshot of global gout therapeutics market by segmentation
Exhibit 28: Snapshot of global gout therapeutics market by geography
Exhibit 29: Global gout therapeutics market revenue by geography 2015-2020 ($ millions)
Exhibit 30: Percentage share of global gout therapeutics market by geography 2015
Exhibit 31: Percentage share of global gout therapeutics market by geography 2020
Exhibit 32: Global gout therapeutics market: Country analysis based on revenue and growth rate
Exhibit 33: Gout therapeutics market in Americas 2015-2020 ($ millions)
Exhibit 34: Gout therapeutics market in EMEA 2015-2020 ($ millions)
Exhibit 35: Opportunity of RDEA3170 in APAC
Exhibit 36: Gout therapeutics market in APAC 2015-2020 ($ millions)
Exhibit 37: Phase III clinical study data and future opportunities for urate-lowering agent – Zurampic (lesinurad)
Exhibit 38: Impact of drivers
Exhibit 39: Common CAM therapies used for gout treatment
Exhibit 40: Usage of CAM therapies in US adults 2015
Exhibit 41: Impact of drivers and challenges
Exhibit 42: Impact of trends on global gout therapeutics market
Exhibit 43: Ranking of major vendors for global gout therapeutics market
Exhibit 44: Geographical presence of key vendors
Exhibit 45: Company portfolio analysis in global gout therapeutics market 2016-2020
Exhibit 46: AstraZeneca: Key highlights
Exhibit 47: AstraZeneca: Strength assessment
Exhibit 48: AstraZeneca: Strategy assessment
Exhibit 49: AstraZeneca: Opportunity assessment
Exhibit 50: Horizon Pharma: Key highlights
Exhibit 51: Horizon Pharma: Strength assessment
Exhibit 52: Horizon Pharma: Strategy assessment
Exhibit 53: Horizon Pharma: Opportunity assessment
Exhibit 54: Takeda Pharmaceuticals: Key highlights
Exhibit 55: Takeda Pharmaceuticals: Strength assessment
Exhibit 56: Takeda Pharmaceuticals: Strategy assessment
Exhibit 57: Takeda Pharmaceuticals: Opportunity assessment


【レポート販売概要】

■ タイトル:痛風治療薬の世界市場2016-2020
■ 英文:Global Gout Therapeutics Market 2016-2020
■ 発行日:2016年10月25日
■ 調査会社:Technavio
■ 商品コード:IRTNTR10483
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。